Can a wearable glucose sensor survive the operating room?

NCT ID NCT06614127

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This pilot study tests whether the Dexcom G7 continuous glucose monitor, a wearable sensor that tracks blood sugar, can maintain a reliable connection during surgery. The device is placed on either the upper arm or the lateral thigh in adults undergoing operations lasting at least three hours. Researchers will measure how often the sensor stays connected, especially during the use of electrocautery, which may interfere with the signal. The goal is to see if this technology can be used effectively in the operating room.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Dexcom G7 continuous glucose monitor
What this could lead to
If the Dexcom G7 stays connected reliably in the operating room, it could enable real-time glucose tracking during surgery, improving safety for patients with diabetes.
What could go wrong
This is a small pilot study, and connectivity may still be unreliable despite the sensor's placement. Results may not apply to all surgical settings or patient types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANESTHESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Loma Linda University Troesch Medical Center

    Loma Linda, California, 92354, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.